Houlihan Lokey Advises GSG GENII Software Group

Houlihan Lokey is pleased to announce that GSG GENII Software Group, a portfolio company of Bregal Unternehmerkapital, has acquired Inlog from Abenex and management, further strengthening its Laboratories division and consolidating its position as a leading European provider of specialised enterprise software.

Founded in 1992 and headquartered in Limonest, France, Inlog is a European leader in healthcare software, specialising in blood transfusion information systems, laboratory information systems, and quality management systems. Its modular, Medical Device Regulation-certified solutions support more than 600 public and private institutions across 12 countries, enabling mission-critical processes in blood banks, hospitals, and laboratories.

Inlog’s ambition is to enhance patient health and optimise healthcare operations through secure, data-driven, and interoperable solutions. The company’s platforms improve patient and donor safety, ensure full data traceability, and strengthen regulatory compliance, while helping caregivers and institutions boost productivity and collaboration. Recognised for its innovation and environmental, social, and governance commitment as an “entreprise à mission,” Inlog empowers healthcare systems to deliver safer, more reliable, and more efficient care worldwide.

For Inlog, the transaction marks the beginning of a new growth chapter. Building on a successful transformation under Abenex, during which the company doubled its revenues, completed three strategic acquisitions, and expanded into Germany and the Benelux, Inlog will now benefit from GENII’s scale and resources to accelerate revenue growth, expand internationally, and drive product innovation, particularly in AI and cloud-based technologies.

Houlihan Lokey served as the buyside financial advisor to GSG GENII Software Group.

RELATED: Technology, Healthcare and Pharma, Mergers & Acquisitions